BioCentury
ARTICLE | Clinical News

PCSK9si: Interim Ph II data

November 3, 2016 11:21 PM UTC

Interim data from the double-blind, placebo-controlled, international Phase II ORION-1 trial in 501 patients with atherosclerotic cardiovascular disease or atherosclerotic cardiovascular disease-risk ...